China is planning to offer an mRNA vaccine as a booster dose for Sinovac and Sinopharm vaccines!
Find out WHY China is switching to an mRNA vaccine!
China To Offer mRNA Booster Dose For Sinovac + Sinopharm!
On 15 July 2021, Caixin Global reported that Chinese drug regulators have completed an expert panel review of a COVID-19 mRNA vaccine that was co-developed by Fosun Pharma with BioNTech from Germany.
The booster dose is currently in the administration review stage, according to Fosun.
Fosun Pharma Chairman Wu Yifang told a shareholder’s meeting on 14 July 2021 that they plan to start domestic trial production by the end of August 2021.
The Chinese authorities plan to use the vaccine – also called COMIRNATY – as a booster dose because inactivated virus vaccines made by Sinovac and Sinopharm “demonstrated lower efficacy“.
This booster dose is likely to be offered for free to those who received vaccines made by Sinovac and Sinopharm.
China administered more than 1.46 billion vaccine doses by 18 July 2021, the vast majority of which were inactivated virus vaccines made by Sinovac and Sinopharm.
It is unknown what role Fosun Pharma played in the development in this booster dose, as they do not appear to have any expertise in developing mRNA vaccines.
It seems likely that their role is mainly to produce the COMIRNATY vaccine doses, with their “co-developed” status offering political cover to the Chinese government, which has long touted the safety and efficacy of their inactivated virus vaccines.
If China approves this mRNA booster dose, I expect the current Chinese propaganda war against Western vaccine technologies, especially the mRNA vaccine, to quickly die down.
They will now have to work hard to convince the Chinese people that mRNA vaccines are actually safe and effective…
Why China Plans To Offer mRNA Booster Dose
On 24 June 2021, Chinese CDC deputy director Dr. Feng Zijian told the China Central Television that antibodies from two Chinese COVID-19 vaccines are “less effective” against the Delta variant, compared to other strains.
Sinovac itself appears to be cognisant of this limitation, and have conducting clinical research on a booster dose of their own.
But it appears that the Chinese government is not going to wait, but will instead boost protection against the Delta variant using an mRNA vaccine instead.
The BioNTech mRNA vaccine booster dose is also using the Pfizer COMIRNATY brand, so it seems likely that this booster dose is either :
- using the existing COMIRNATY vaccine, or
- the new vaccine version Pfizer and BioNTech are developing against the Delta variant
It seems more likely that the booster dose uses the existing COMIRNATY vaccine, because Pfizer and BioNTech are only launching clinical trials for the new vaccine version in August 2021.
- COVID-19 Vaccination For Children Postponed For Now!
- How Chinese Vaccine Propaganda Hobbles Vaccination Efforts
- Fact Check : Ivermectin Triple Therapy By Professor Borody
- CITF : Walk-In Vaccination Details To Be Announced LATER!
- Malaysia : +3 Million Sinovac Doses, Private Sale Soon!
- Walk-In Vaccination In Malaysia From 1 August Onwards?
- What To Do Before, During + After COVID-19 Vaccination?
- Malaysia Has 4 Most Dangerous COVID-19 Cities In Asia?
- Delta Variant Can Infect In Seconds : How To Prevent That?
- Scam Alert : Ziverdo Kit To Treat COVID-19!